These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 17540369

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury.
    Bartus K, James ND, Didangelos A, Bosch KD, Verhaagen J, Yáñez-Muñoz RJ, Rogers JH, Schneider BL, Muir EM, Bradbury EJ.
    J Neurosci; 2014 Apr 02; 34(14):4822-36. PubMed ID: 24695702
    [Abstract] [Full Text] [Related]

  • 3. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition.
    Jones LL, Sajed D, Tuszynski MH.
    J Neurosci; 2003 Oct 15; 23(28):9276-88. PubMed ID: 14561854
    [Abstract] [Full Text] [Related]

  • 4. Axonal regeneration of Clarke's neurons beyond the spinal cord injury scar after treatment with chondroitinase ABC.
    Yick LW, Cheung PT, So KF, Wu W.
    Exp Neurol; 2003 Jul 15; 182(1):160-8. PubMed ID: 12821386
    [Abstract] [Full Text] [Related]

  • 5. Degradation of chondroitin sulfate proteoglycans potentiates transplant-mediated axonal remodeling and functional recovery after spinal cord injury in adult rats.
    Kim BG, Dai HN, Lynskey JV, McAtee M, Bregman BS.
    J Comp Neurol; 2006 Jul 10; 497(2):182-98. PubMed ID: 16705682
    [Abstract] [Full Text] [Related]

  • 6. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury.
    Jones LL, Margolis RU, Tuszynski MH.
    Exp Neurol; 2003 Aug 10; 182(2):399-411. PubMed ID: 12895450
    [Abstract] [Full Text] [Related]

  • 7. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors.
    Jones LL, Yamaguchi Y, Stallcup WB, Tuszynski MH.
    J Neurosci; 2002 Apr 01; 22(7):2792-803. PubMed ID: 11923444
    [Abstract] [Full Text] [Related]

  • 8. Combined chondroitinase and KLF7 expression reduce net retraction of sensory and CST axons from sites of spinal injury.
    Wang Z, Winsor K, Nienhaus C, Hess E, Blackmore MG.
    Neurobiol Dis; 2017 Mar 01; 99():24-35. PubMed ID: 27988344
    [Abstract] [Full Text] [Related]

  • 9. NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury.
    Buss A, Pech K, Kakulas BA, Martin D, Schoenen J, Noth J, Brook GA.
    BMC Neurol; 2009 Jul 15; 9():32. PubMed ID: 19604403
    [Abstract] [Full Text] [Related]

  • 10. Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury.
    Andrews EM, Richards RJ, Yin FQ, Viapiano MS, Jakeman LB.
    Exp Neurol; 2012 May 15; 235(1):174-87. PubMed ID: 21952042
    [Abstract] [Full Text] [Related]

  • 11. Benefit of chondroitinase ABC on sensory axon regeneration in a laceration model of spinal cord injury in the rat.
    Shields LB, Zhang YP, Burke DA, Gray R, Shields CB.
    Surg Neurol; 2008 Jun 15; 69(6):568-77; discussion 577. PubMed ID: 18486695
    [Abstract] [Full Text] [Related]

  • 12. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries.
    Davies JE, Tang X, Denning JW, Archibald SJ, Davies SJ.
    Eur J Neurosci; 2004 Mar 15; 19(5):1226-42. PubMed ID: 15016081
    [Abstract] [Full Text] [Related]

  • 13. Expressing Constitutively Active Rheb in Adult Neurons after a Complete Spinal Cord Injury Enhances Axonal Regeneration beyond a Chondroitinase-Treated Glial Scar.
    Wu D, Klaw MC, Connors T, Kholodilov N, Burke RE, Tom VJ.
    J Neurosci; 2015 Aug 05; 35(31):11068-80. PubMed ID: 26245968
    [Abstract] [Full Text] [Related]

  • 14. IT delivery of ChABC modulates NG2 and promotes GAP-43 axonal regrowth after spinal cord injury.
    Novotna I, Slovinska L, Vanicky I, Cizek M, Radonak J, Cizkova D.
    Cell Mol Neurobiol; 2011 Nov 05; 31(8):1129-39. PubMed ID: 21630006
    [Abstract] [Full Text] [Related]

  • 15. Role of chondroitin sulfate proteoglycans in axonal conduction in Mammalian spinal cord.
    Hunanyan AS, García-Alías G, Alessi V, Levine JM, Fawcett JW, Mendell LM, Arvanian VL.
    J Neurosci; 2010 Jun 09; 30(23):7761-9. PubMed ID: 20534825
    [Abstract] [Full Text] [Related]

  • 16. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue.
    Tang X, Davies JE, Davies SJ.
    J Neurosci Res; 2003 Feb 01; 71(3):427-44. PubMed ID: 12526031
    [Abstract] [Full Text] [Related]

  • 17. Transplantation of canine olfactory ensheathing cells producing chondroitinase ABC promotes chondroitin sulphate proteoglycan digestion and axonal sprouting following spinal cord injury.
    Carwardine D, Prager J, Neeves J, Muir EM, Uney J, Granger N, Wong LF.
    PLoS One; 2017 Feb 01; 12(12):e0188967. PubMed ID: 29228020
    [Abstract] [Full Text] [Related]

  • 18. Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord.
    Houle JD, Tom VJ, Mayes D, Wagoner G, Phillips N, Silver J.
    J Neurosci; 2006 Jul 12; 26(28):7405-15. PubMed ID: 16837588
    [Abstract] [Full Text] [Related]

  • 19. Chondroitin sulfate proteoglycans in spinal cord contusion injury and the effects of chondroitinase treatment.
    Iaci JF, Vecchione AM, Zimber MP, Caggiano AO.
    J Neurotrauma; 2007 Nov 12; 24(11):1743-59. PubMed ID: 18001203
    [Abstract] [Full Text] [Related]

  • 20. Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase.
    Moon LD, Asher RA, Fawcett JW.
    J Neurosci Res; 2003 Jan 01; 71(1):23-37. PubMed ID: 12478611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.